Notes
over-the-counter
References
Pharmaceuticals and Medical Devices Agency. Summary of investigation results - Flunitrazepam (injections). Internet Document : 22 Mar 2016. Available from: URL: http://www.pmda.go.jp/files/000211013.pdf
Pharmaceuticals and Medical Devices Agency. Summary of investigation results - Furosemide. Internet Document : 22 Mar 2016. Available from: URL: http://www.pmda.go.jp/files/000211017.pdf
Pharmaceuticals and Medical Devices Agency. Summary of investigation results - Loxoprofen sodium hydrate (for oral use). Internet Document : 22 Mar 2016. Available from: URL: http://www.pmda.go.jp/files/000211014.pdf
Pharmaceuticals and Medical Devices Agency. Summary of investigation results - Products containing loxoprofen sodium hydrate (OTC drugs for oral use). Internet Document : 22 Mar 2016. Available from: URL: http://www.pmda.go.jp/files/000211022.pdf
Pharmaceuticals and Medical Devices Agency. Summary of investigation results - Mirabegron. Internet Document : 22 Mar 2016. Available from: URL: http://www.pmda.go.jp/files/000211021.pdf
Pharmaceuticals and Medical Devices Agency. Summary of investigation results - Risperidone (injections), Paliperidone palmitate. Internet Document : 22 Mar 2016. Available from: URL: http://www.pmda.go.jp/files/000211015.pdf
Pharmaceuticals and Medical Devices Agency. Summary of investigation results - Verteporfin. Internet Document : 22 Mar 2016. Available from: URL: http://www.pmda.go.jp/files/000211016.pdf
Rights and permissions
About this article
Cite this article
Japan's PMDA releases investigation results for 8 products. Reactions Weekly 1595, 5 (2016). https://doi.org/10.1007/s40278-016-16037-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-016-16037-4